Venous Valve Reconstruction in Patients with Secondary Chronic Venous Insufficiency  by Rosales, A. et al.
Eur J Vasc Endovasc Surg (2008) 36, 466e472Venous Valve Reconstruction in Patients with
Secondary Chronic Venous InsufficiencyA. Rosales*, J.J. Jørgensen, C.E. Slagsvold, E. Stranden,
Ø. Risum, A.J. KroeseOslo Vascular Centre, Aker University Hospital and Faculty of Medicine, University of Oslo, Norway
Submitted 15 October 2007; accepted 8 June 2008





Venous reflux* Corresponding author. A. Rosales, D
Tel.: þ47 2289 4000; fax: þ47 2222 5
E-mail address: anto-r@online.no
1078-5884/$34 ª 2008 European Socie
doi:10.1016/j.ejvs.2008.06.015Abstract Objectives: To evaluate the durability of venous valve reconstruction (VVR) and its
benefits in terms of symptom improvement, ulcer healing and symptom/ulcer recurrence
among patients with secondary chronic venous insufficiency (SCVI) in whom superficial venous
surgery and compression treatment had failed.
Methods: During a ten year period (1993e2004) 1800 patients with chronic venous insuffi-
ciency (CVI) were evaluated by colour duplex ultrasound (CDU) and ambulatory venous pres-
sure measurement (AVP). Approximately two thirds of patients had SCVI. Initial treatment
consisted of compression therapy for a 6 month period. In addition, superficial vein and per-
forator surgery was performed in those presenting with reflux in these venous systems. 121
patients who did not improve with this treatment were investigated by ascending venogra-
phy, descending video venography, air plethysmography and measurement of post-ischaemic
venous pressure gradient. Thirty two cases having venous reflux without obstruction were
selected for VVR.
Results: The ulcer healing rate within three months was 68% (13/19 patients). VVR resulted
in valvular competence and a clinical success rate of 47% and 40% after 3 and 7 years respec-
tively. In 8/13 (54%) of patients with a healed leg ulcer, a median post-operative AVP reduc-
tion of 33 mm Hg (range 20e38) was recorded. The durability of clinical success was
numerically longer in patients with haemodynamic improvement (nZ 10) median 24 months
(12e108), when compared with that in those without haemodynamic improvement (nZ 22)
median 18 months (6e108). Popliteal vein reconstruction was part of the VVR procedure in
all patients with haemodynamic improvement (post-op. AVP reduction 20 mmHg). VVR at
the popliteal level alone or combined with inguinal reconstruction seemed to be the one sig-
nificant factor associated with haemodynamic improvement (PZ 0.014, Chi squared).epartment of Vascular Surgery, Oslo Vascular Centre, Aker University Hospital, N-0514 Oslo, Norway.
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Vein valve reconstruction in venous insufficiency 467Conclusion: VVR may lead to ulcer healing, but when performed at the popliteal level, hae-
modynamic improvement can be obtained along with a longer recurrence-free period (dura-
bility). VVR should be considered in the treatment of patients with SCVI who do not respond
to superficial venous surgery and compression treatment.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
The incidence of deep venous thrombosis (DVT) remains as
high as 160/100 000/per year, despite the increasing use of
prophylaxis with low molecular weight heparins (LMWH)
during hospital treatment.1 Long-term follow-up studies
have shown that as many as 40% of patients suffering an
episode of DVT will develop secondary chronic venous in-
sufficiency (SCVI), by which we mean venous disease re-
sulting in skin changes and leg ulceration.2,3 Venous
valve destruction occurs during both the acute inflamma-
tory phase of thrombosis and during the reabsorption the
thrombi which in turn may lead to venous reflux or outflow
obstruction. The serious clinical consequences of this pro-
cess are leg ulceration or venous claudication experienced
by at least 15% of patients with SCVI.4 The main stay of
the treatment for patients with SCVI is compression ther-
apy combined with anticoagulation in patients experienc-
ing recurrent thrombotic episodes due to hereditary
thrombophilia.5e9
Venous valve reconstruction (VVR) has had a limited
role in the treatment of this group of patients. This is
partly due to the need for accurate pre-operative haemo-
dynamic evaluation, clear indications for operation and
demanding operative technique.10e12 In addition, chronic
venous insufficiency is a chronic disease under-prioritised
in most surgical units and the reported results do not
seem to have had the necessary impact in the vascular
surgery community.
The aim of our study was to evaluate the durability of
VVR and its benefits in terms of symptom improvement,
ulcer healing and symptom or ulcer recurrence among
patients with SCVI in whom conventional treatment had
failed.
Patients and Methods
Between 1993 and 2004, 1800 patients with chronic venous
insufficiency (CVI) resulting in skin changes or leg ulcers
were evaluated in our vein clinic with colour duplex
ultrasound (CDU) and ambulatory venous pressure mea-
surement (AVP). In approximately two thirds of patients
SCVI was diagnosed on the basis of the clinical history and
CDU findings. These patients were treated by conservative
compression therapy for six months. In addition, superficial
and perforator surgery was performed in those with venous
incompetence affecting these vessels. A group of 121
patients did not improve with this treatment and was
further investigated with ascending venography, descend-
ing video venography, air plethysmography and measure-
ment of post-ischaemic venous pressure gradient (modified
Raju’s test).13 Fifty-two cases with reflux and/or outflow
obstruction were identified as amenable for reconstructivedeep venous surgery (RDVS). Those patients with venous re-
flux who did not have venous outflow obstruction (nZ 32)
constitute the patients included in the present study.
Inclusion criteria:
 Symptomatic SCVI patients (C4-C6) in whom compres-
sion therapy for at least 6 months, combined with
superficial venous and perforator surgery where appro-
priate, failed to obtain clinical improvement.
 SCVI patients presenting evidence of venous reflux
without outflow obstruction.
 Age 70 years
Exclusion criteria:
 SCVI patients with evidence of venous outflow
obstruction
 Ankle arthrodesis with secondary muscle atrophy
 Age> 70 years
 General contraindications to surgery
Patients were examined clinically by a surgeon experi-
enced in the management of venous disease and the
appropriate CEAP classification assigned to each patient.14
Investigations
Ambulatory venous pressure (AVP) measurement was used
to assess global reflux, function of the veno-muscular
pump and the severity of venous hypertension. AVP pro-
vides information about a pressure drop with ambulation
(a measure of the venous pump function), ambulatory pres-
sure and recovery time.
Colour duplex ultrasound (CDU) was used to evaluate
axial reflux in the different anatomical segments of each
venous system.
Descending video venography is a dynamic imaging of
the venous valve leaflets that may be amenable to repair
and allows classifying the severity of the axial reflux
according to Kistner: Grade I proximally in the thigh, Grade
II above the knee, Grade III below the knee, Grade IV to the
ankle.15 These methods have been described in detail
previously.16
To evaluate the haemodynamic significance of a post-
thrombotic vein occlusion two additional investigations
were performed:
Venous occlusion plethysmography (VOP) is performed
to exclude persistent venous outflow obstruction by using
an air plethysmograph (MacroLab, E. Stranden). In the
recumbent position venous occlusion and recording cuffs
were applied proximally to the patella and at the calf,
respectively. An occlusive cuff pressure of 50 mmHg was
maintained for one minute. This permits uninhibited arte-
rial flow into the limb, while the venous outflow is
Figure 1 The venous segment containing a competent valve is transplanted as an interposition by using in-lay technique. The
native vessel is ‘‘wrapped’’ around as reinforcement. Diameter discrepancy, thickening and fibrosis of the native vessel pose
the major technical challenges in this procedure.
Figure 2 ‘‘Strip test’’ is performed to confirm the compe-
tency of the procedures.
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compression of the thigh cuff the leg volume decreases rap-
idly when the venous outflow is normal. In the presence of
a functional venous obstruction the leg volume will
decrease slowly. Normally on decompression the empty ve-
locity is 25 mm/second.
Venous pressure gradient is obtained by comparing
venous pressure measurements before and after a reactive
hyperaemia test of the lower extremity. An inflatable tour-
niquet is applied to the thigh, and venous pressure is
recorded in a superficial leg vein. With the patient in supine
position a basal measurement is made. The thigh tourni-
quet is then inflated to 300 mmHg pressure and maintained
for 3 minutes. After releasing the tourniquet, reactive
hyperaemia increases venous outflow. A normal outflow
resistance ensures a concomitant venous pressure increase
under 8 mmHg. Levels above 8 mmHg will suggest an out-
flow obstruction.13
Surgical Technique
Postthrombotic changes leading to reflux do not develop in
a fixed pattern. The use of different surgical techniques in
the one patient may be necessary adequately to deal with
all incompetent deep veins.
Autotransplantation
The main objective of VVR is to abolish reflux in both
femoral and/or popliteal veins. A vein diameter <5 mm
and signs of fibrosis/trabecula diagnosed by CDU and/or
venography are our criteria to rule out those veins not
fit for auto-transplant. A competent valve is identified
preoperatively with CDU in the axillary or the saphenous
veins. A 6e8 cm long vein segment containing a function-
ing valve is harvested. The valve is tested by injecting sa-
line solution. Sometimes the axillary vein valve is foundincompetent after it has been harvested and a bench ex-
ternal plasty must be performed. In the groin the femoral
vein is exposed through a longitudinal incision, whereas in
the popliteal fossa we use a posterior approach and an
S-shape incision. The venous segment containing a compe-
tent valve is then implanted as an interposition by using
in-lay suturing technique (Fig. 1). This involves two
end-to-end anastomoses with 6-0 polypropylene. We use
a running suture, interlocking every other suture, to avoid
a ‘‘purse-string’’ effect. The cranial anastomosis is per-
formed first. The ‘‘strip test’’ confirms the competence
of the transplant Fig. 2. The native vessel is ‘‘wrapped’’
around as reinforcement without compromising the valve
function. Diameter discrepancy, thickening and fibrosis
of the native vessel pose the major technical challenges
in this procedure. The donor sites chosen were the
saphenous (contralateral or ipsilateral) and axillary veins.
The great and small saphenous veins were used as the
Figure 4 Transposition involves taking a refluxive post-
thrombotic vein segment and anastomosing it end-to-side,
distally to a competent valve.
Figure 3 The surgical technique of external venous valve plasty assisted by angioscopy: a view of incompetent valve cusps and
the first external suture placed in a commissure (a), external sutures in both commissures (b) and the finished valve repair.
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six cases the axillary vein was used as donor. Auto-
transplantation to the popliteal level was performed in
24 patients.
External venous valve plasty
In some SCVI patients descending video-venography and
CDU show incompetent but not damaged venous valves
amenable to repair. In these cases we use the external
venous valve plasty technique. Details of the technique are
previously described.11,16 (Fig. 3).
Transposition
Occasionally a vein transposition procedure was performed.
This involves taking an incompetent post-thrombotic vein
segment and anastomosing it end-to-side, distally to a com-
petent valve, for example the superficial femoral vein
anastomosed distally to a competent valve in the great
saphenous vein.11,16 (Fig. 4).
All procedures were performed by the same surgical
team and were tested intra-operatively using a retrograde
flow test (strip-test) in order to confirm that competence
had been restored to the operated veins.
Anticoagulation
Pre-and intra- operative full anticoagulation is used with
LMWH and continued for six months postoperatively. We
use dalteparin 200 IU/kg body weight/daily administered
subcutaneously. Those patients with a hereditary
Table 1 Thrombophilias detected in this series of SCVI
patients (14/32)
Haematological defect N
Protein C deficiency 4
Protein S deficiency 4
Activated protein C resistance 3
Anti-thrombin 2
Homocysteinuria 1
Table 2 CEAP classification and ambulatory venous
pressure levels of the 32 patients in this series (values are
the median and range)
CEAP groups
C N AVP mmHg
C4 2 93 (76e110)
C5 11 80 (60e90)
C6 19 88 (68e125)
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coagulation with warfarin.6
Follow-up and definitions
Patients were followed-up at three months and thereafter
every 6 months by clinical examination, CDU and AVP. The
median follow-up period was 24 months (6e108). Clinical
success was defined as symptom relief and/or ulcer healing.
The patient’s ability to go back to work and normal activity
after VVR and the subjective experience of symptom im-
provement were the two parameters used to define symp-
tom relief. Haemodynamic improvement was defined as
a post-operative AVP reduction of 20 mmHg. The clinical
endpoints were ulcer- and/or symptom recurrence. The
number of months that a reconstruction remained compe-
tent verified with CDU is referred to as durability.
Statistics
We have chosen a follow-up study of patients with SVCI
submitted to VVR describing the incidence of clinical
success and haemodynamic improvement of this surgical
method. Analysis was done using 2 2 contingency tables
applying the Yates chi-square test, Fischer’s exact test
and Kaplan Meier survival probability method. All the
descriptors for all data are given the median and range.
Results
Amongst the 32 patients were 27 men and 5 women. Median
age was 47 years (range: 25e66). All patients had a history of
at least had one episode of DVT verified by ultrasound or
venography. The median time elapsed after the first DVTTable 3 a and b. Type of surgery performed in each patient an
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Femþ Pop 2 3episode was 16.3 years (range 1.5e35). The following
conditions were identified as possible trigger factors for DVT:
a) Thrombophilia (14), b) surgery/trauma (7), c) sponta-
neous/unknown (7), d) post-partum (3) and d) inflammatory
bowel disease (1). Fourteen patients (44%) had an inherited
thrombophilia (Table 1). In 9/14 patients this diagnosis was
not established until they consulted our vein clinic. Prior to
VVR, 22/32 patients were operated on to abolish superficial
vein (18), perforator (1) and combined (3) reflux.
All patients had deep reflux in the popliteal and crural
veins levels shown by CDU. Descending video-venography
showed nine cases with reflux grade III and 23 with grade IV
according to Kistner’s classification.17 High levels of AVP
were recorded in all clinical groups (Table 2).
Forty-three procedures were performed in 32 patients.
Twenty-one patients received single procedures and 11
patients multiple procedures (all multilevel). Several differ-
ent techniques were used, but in the majority of cases
a venous valve auto-transplant was performed (32/43).
External venous valve plasty and venous transposition were
combinedwith transplant and/or used alone (Table 3a and b).
At three months follow-up 26/32 (81%) patients had
competent valve plasties. Four patients presented with
incompetent transplanted valves which were regarded as
failures, and two patients with thrombosed single trans-
plants. Clinical success (defined as symptom relief and/or
ulcer healing) was accomplished in 25/32 (78%) Table 4. Ul-
cer healing was accomplished in 13/19 patients (68%), and
other 12 patients had symptom relief.
Haemodynamic improvement (post-op. AVP reduction
20 mmHg) was observed in 10 patients. All patients with
haemodynamic improvement obtained clinical success but
not all with clinical success experienced haemodynamic
improvement (Table 5).
In 8/13 (54%) patients who healed an ulcer post-
operatively, a median post-operative AVP reduction of
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Table 4 Clinical success after VVR over the follow-up
period
Table 6 AVP reduction and popliteal reconstruction to-
gether lead to longer ulcer-free period
Table 7 Venous Valve Reconstruction (VVR) competence
and clinical success in the follow-up period
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median durability of 24 months (range 12e108), while in
those without haemodynamic improvement (nZ 22) the
median durability was 18 months (range 6e108). This dif-
ference was not statistically significant.
A popliteal reconstruction had been performed in all
patients (10/10) with haemodynamic improvement, and in
14/22 without. VVR at the popliteal level alone or com-
bined with inguinal reconstruction was found to be the one
significant factor associated with haemodynamic improve-
ment (pZ 0.014, Chi squared). Durability of VVR was longer
in those with a popliteal reconstruction, median 24 months
(6e108) when compared to those without it, median 6
months (6e84). Popliteal reconstruction and haemody-
namic improvement together provided the best durability
and the longer recurrence-free period (Table 6). Multiple-
repairs (nZ 11) seemed to have a greater numerical dura-
bility, although this did not reach statistical significance.
Among those with clinical success 13 patients (C5-C6)
had an ulcer-free and symptom-free period of median 36
(range 6e108) months and have not yet reached an
endpoint. The two patients in the C4 group had a symp-
tom-free period of 12 and 36 months, respectively. In the
C5 group 7/9 reached endpoint after a median recurrence-
free period of 24 (range 6e84) months. And in the C6 groupTable 5 Number of patients experiencing clinical success
(symptom relief and/or ulcer healing) related to haemody-
namic improvement (Post op. AVP reduction of 20 mmHg)
in the different CEAP groups
C N Clinical success Haemodynamic improvement
C4 2 2 2
C5 11 9 1
C6 19 14 7
Total 32 25 105/13 reached endpoint after an ulcer-free period of median
12 (range 6e24) months.
Table 7 illustrates the durability and clinical success rate
in the follow-up period, 47% and 40% after 3 and 7 years,
respectively.
Three of the six auto-transplants from the axillary vein
became incompetent within 6 months, while the other
three have been competent a median of 108 (range
72e108) months.
Of the 26 auto-transplants from saphenous veins 12 were
incompetent after a median of 24 (6e60) months and 14
had a competent period of median 30 (6e72) months.
Discussion
Detailed knowledge of the underlying venous pathophysi-
ology is mandatory in planning effective treatment in
patients with SCVI. One should be acquainted with the
472 A. Rosales et al.various VVR techniques and how to combine them to
achieve the best haemodynamic results. Auto-transplanta-
tion was, by far, the most commonly used procedure (32/
43) in this series of VVR in SCVI patients. We introduced our
choice of in-lay technique to interpose the vein segment
containing a competent valve, where the native vein is
wrapped around as a reinforcing cuff without compromising
the valve function.
Clinical success seemed to be directly related to the
competence of VVR. Haemodynamic improvement assessed
by AVP reduction is associated with ulcer healing.
Reconstructing the popliteal level appears to be a key
factor (pZ 0.014) in accomplishing haemodynamic
improvement. Popliteal reconstruction and haemodynamic
improvement combined, provided the best durability and
the longer recurrence-free period in these group of
patients. Regardless the clinical stage it would appear
that the durability of the reconstruction stabilizes around
24 months as seen in Table 6. Our long term results compare
favourably to those reported in the literature by Kistner
et al.12 but are inferior to those of Raju’s.10 We were
unable to prove that a saphenous vein is a better donor
than the axillary vein, but have at least demonstrated
that saphenous veins can actually be used effectively.
Testing for clotting factor abnormalities should be a part
of the evaluation of these post-thrombotic patients since
nearly 40% of our cases had a thrombophilia.
In the present study the performance of VVR in a se-
lected group of patients led to ulcer-free periods with
a reduced ulcer recurrence rate. Considering that these are
patients who have not responded to other more conserva-
tive forms of treatment underscores the value of our results
and the opportunity to improve their quality of life. In
addition, according to Tennvall,18 101 euros can be saved in
healthcare resources for each week a venous ulcer remains
healed. These savings together with a reduction in sickness-
leave are socio-economical benefits suggested by the dura-
bility in our results. Hopefully this positive experience will
encourage the allocation of more resources and medical at-
tention to deal with this rather neglected secondary form
of CVI.
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